Clinical Trials Browser

Terminated × daratumumab × 90 days × Clear all

NCT04824794 2026-05-19

GEN3014 Trial in Relapsed or Refractory Hematologic Malignancies

Phase 1/2 Terminated

130 enrolled 40 charts

LymphoidOther hematologic neoplasmPlasma cell

Multiple Myeloma, Recurrence, Leukemia, Myeloid, Acute, Lymphoma, Large B-Cell, Diffuse

NCT03757221 2026-05-13

IDARA

Phase 2 Terminated

Multiple Myeloma

NCT03622775 2026-04-24

Daratumumab in Treating Participants With Relapsed Multiple Myeloma After Stem Cell Transplant

Phase 2 Terminated

13 enrolled 9 charts

Multiple Myeloma